CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −30,000 | 95,000 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +30,000 | 145,000 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −56,350 | 281,750 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +56,350 | 169,050 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −16,666 | 50,000 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +16,666 | 16,666 | ||
| 2024-07-12 | GUYER DAVID R Director | Option exercise 10b5-1 | +3,250 | $3.50 | $11K | 6,950 |
| 2024-07-12 | GUYER DAVID R Director | Option exercise 10b5-1 | +6,525 | $3.26 | $21K | 13,475 |
| 2024-07-12 | GUYER DAVID R Director | Sale 10b5-1 | −11,625 | $10.06 | $117K | 1,850 |
| 2024-07-12 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,250 | 3,250 | ||
| 2024-07-12 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,525 | 6,525 | ||
| 2024-07-11 | Zaderej Karen L. Director | Option exercise | +2,000 | 4,000 | ||
| 2024-07-11 | Zaderej Karen L. Director | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2024-07-10 | Duker Jay S. President and CEO | Option exercise | +16,666 | 46,086 | ||
| 2024-07-10 | Duker Jay S. President and CEO | Shares withheld for taxes | −8,059 | $8.69 | $70K | 38,027 |
| 2024-07-10 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −16,666 | 33,334 | ||
| 2024-07-10 | Lurker Nancy Executive Vice Chair | Option exercise | +11,111 | 94,462 | ||
| 2024-07-10 | Lurker Nancy Executive Vice Chair | Option exercise · Restricted Stock Units | −11,111 | 22,223 | ||
| 2024-06-23 | ADAMIS ANTHONY P Director | Option exercise | +2,000 | 4,000 | ||
| 2024-06-23 | ADAMIS ANTHONY P Director | Option exercise · Restricted Stock Units | −2,000 | 2,000 |
Page 9 of 18 · 352 trades